ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 5 ( 27 )’ 2016
17 . Tsutani Y ., Miyata Y ., Nakayama H ., et al . Prediction of pathological node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection // J . Thorac . Cardiovasc . Surg . – 2012 . – № 6 ( 144 ). – P . 1365-1371 .
18 . Tsutani Y ., Miyata Y ., Nakayama H ., et al . Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting malignant grade of tumors in clinical stage IA lung adenocarcinoma : a multicenter study // J . Thorac . Cardiovasc . Surg . – 2012 . – № 3 ( 143 ). – Р . 607-612 .
19 . Tsutani Y ., Miyata Y ., Misumi K ., et al . Difference in prognostic significance of maximum standardized uptake value on [ 18F ] -fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung // Jpn J . Clin . Oncol . – 2011 . – Vol . 41 . – P . 890-896 .
20 . Tsutani Y ., Murakami S ., Miyata Y ., et al . Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung // Eur . J . Cardiothorac . Surg . – 2015 . – № 6 ( 47 ). – P . 1022-1026 .
21 . Uehara H ., Tsutani Y ., Okumura S ., et al . Prognostic role of positron emission tomography and highresolution computed tomography in clinical stage IA lung adenocarcinoma // Ann . Thorac . Surg . – 2013 . – № 6 ( 96 ). – Р . 1958-1965 .
22 . Zhang Y ., Sun Y ., Xiang J ., et al . A prediction model for N2 disease in T1 non-small cell lung cancer // J . Thorac . Cardiovasc . Surg . – 2012 . – № 6 ( 144 ). – Р . 1360-1364 .
24 Клинические исследования и опыт в онкологии